Core Viewpoint - Walgreens Boots Alliance, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its compliance with federal laws related to prescription medication [3][4]. Summary by Relevant Sections Allegations - The lawsuit claims that during the class period from April 2, 2020, to January 16, 2025, Walgreens engaged in widespread violations of federal law concerning the dispensation of prescription medication and reimbursement [3]. - It is alleged that Walgreens' revenues from prescription medication sales were unsustainable as they were derived from unlawful conduct, which could lead to increased regulatory scrutiny, civil liability, and reputational harm [3]. Class Action Details - Shareholders who purchased WBA shares during the specified class period are encouraged to register for the class action, with a deadline set for March 31, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers.  The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Walgreens common stock between April 2, ...

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Walgreens common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Walgreens Boots Alliance, Inc. common stock between April 2, 2020, and January 16, 2025, of the March 31, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Walgreens common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit alleges that Walgreens failed to disclose significant issues regarding regulatory compliance and unlawful conduct related to prescription medication, which led to misleading public statements and potential damages for investors [4]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering substantial amounts for investors [5]. - Investors are informed that no class has been certified yet, meaning they are not represented unless they retain counsel, and they can choose to remain absent from the class [7].

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/? id=137118&from ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Walgreens Boots Alliance (WBA) reports results for the quarter ended February 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, th ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/walgreens- ...

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=136057&from= ...

NEW YORK, March 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots- ...

Core Viewpoint - Walgreens Boots Alliance, Inc. is facing a class action lawsuit due to allegations of false statements and regulatory violations during the Class Period from April 2, 2020, to January 16, 2025 [1][3]. Group 1: Legal Allegations - The lawsuit claims that Walgreens violated federal laws regarding prescription medication dispensation and reimbursement, despite its stated commitment to regulatory compliance [3]. - It is alleged that these violations led to increased regulatory scrutiny, civil liability, and reputational harm for Walgreens [3]. - The lawsuit further asserts that Walgreens' prescription medication revenues were unsustainable, as they were partially derived from unlawful practices [4]. Group 2: Regulatory Actions and Impact - On January 17, 2025, the U.S. Department of Justice filed a civil complaint against Walgreens for dispensing millions of unlawful prescriptions in violation of the Controlled Substances Act and seeking reimbursement from federal health care programs in violation of the False Claims Act [5]. - Following the announcement of the DOJ complaint, Walgreens' stock price experienced a decline of more than 12% over two trading sessions [5].